Taro Iwamoto

10PUBLICATIONS

45CO-AUTHORS

Rheumatology and arthritisInnate immunityDisease surveillanceAutoimmunityMedical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 12, 2026

Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J).

|Aug 06, 2025

Rapid resolution of fever and panniculitis after anifrolumab in a patient with systemic lupus erythematosus refractory to standard immunosuppression.

Shunichiro Hanai, Yoshiaki Kobayashi, Taro Iwamoto

|Feb 22, 2024

Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.

Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi

|Jan 26, 2024

Refractory systemic lupus erythematosus with neuropsychiatric manifestations successfully treated with anifrolumab.

Y Kobayashi, S Hanai, T Iwamoto

|Jan 12, 2024

Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.

Tomoaki Ida, Shunsuke Furuta, Michio Fujiwara

|Jul 17, 2023

Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database study.

Tomoaki Ida, Kei Ikeda, Hiroyuki Ohbe

Pageof 2

Frequent Collaborators

Daiki Nakagomi

Kei Ikeda

Tomoaki Ida

Hiroshi Nakajima

Yoshihisa Kobayashi

Yoshiaki Kobayashi

Shunichiro Hanai

Manami Kato

Shin-Ichiro Kagami

Shunsuke Furuta

Frequent Collaborators

Daiki Nakagomi

Kei Ikeda

Tomoaki Ida

Hiroshi Nakajima